Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $46,794 - $61,827
-309 Reduced 21.14%
1,153 $228 Million
Q3 2023

Nov 14, 2023

SELL
$167.14 - $192.77 $37,105 - $42,794
-222 Reduced 13.18%
1,462 $254 Million
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $8,529 - $9,870
53 Added 3.25%
1,684 $290 Million
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $1,163 - $1,400
-8 Reduced 0.49%
1,631 $271 Million
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $214,938 - $258,093
1,639 New
1,639 $240 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bos Asset Management, LLC Portfolio

Follow Bos Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bos Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bos Asset Management, LLC with notifications on news.